Citation Impact
Citing Papers
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
2013 StandoutNobel
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: The randomized evaluation of strategies for left ventricular dysfunction pilot study
2000
Survivors of out-of-hospital cardiac arrest with apparently normal heart: Need for definition and standardized clinical evaluation
1997
High prevalence of right ventricular involvementin endurance athletes with ventricular arrhythmias Role of an electrophysiologic study in risk stratification
2003
Cardiomyopathy, familial dilated
2006
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET
2005
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Use of carvedilol in chronic heart failure: Challenges in therapeutic management
1998
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
1995
Effects of Beta-Adrenergic Blockade on Survival of Patients With Chronic Heart Failure
1997
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-Blockers
2008
Prospects for Cardiovascular Research
2001 StandoutNobel
Hereditary dilated cardiomyopathy
1995
Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
2007
Wound repair and regeneration
2008 StandoutNature
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
2004
Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients
2010
The arrhythmogenic right ventricle. Dysplasia versus cardiomyopathy
1995
Evidence of Apoptosis in Arrhythmogenic Right Ventricular Dysplasia
1996 Standout
ARVD4, a New Locus for Arrhythmogenic Right Ventricular Cardiomyopathy, Maps to Chromosome 2 Long Arm
1997
Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria
2002
Decennial follow-up in patients with recurrent tachycardia originating from the right ventricular outflow tract: electrophysiologic characteristics and response to treatment
2007
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
1998
Magnetic Resonance Imaging Abnormalities in Right Ventricular Outflow Tract Tachycardia and the Prediction of Radiofrequency Ablation Outcome
2006
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
2011 Standout
Right ventricular dysplasia: an ultrastructural study
1989
Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
2005
Update on recent clinical trials in congestive heart failure
2000
Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials
2002
Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia
2010
Clinical and genetic issues in familial dilated cardiomyopathy
2005
Autoimmunity in Myocarditis: Relevance of Animal Models
1997
Sudden cardiac death in younger adults: autopsy diagnosis as a tool for preventive medicine
2006
Heart failure disease management: a critical review
1999
Drug-induced heart failure
1999
Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular Cardiomyopathy
2009
Recognition and Optimum Management of Myocarditis
1996
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Arrhythmogenic right ventricular cardiomyopathy
2009
Successes and failures of current treatment of heart failure
1998
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
The Management of Chronic Heart Failure
1996
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
1994
Pharmacology of carvedilol
2004
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
1995
Characterization of coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products
1998
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
2010
Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
1997
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
2003
Signal-averaged electrocardiogram in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular arrhythmias
2000
Cancer immunotherapy comes of age
2011 StandoutNature
Electrocardiographic Comparison of Ventricular Arrhythmias in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Right Ventricular Outflow Tract Tachycardia
2011
Mechanism of Action of Beta-Blocking Agents in Heart Failure
1997
Why does the myocardium fail? Insights from basic science
1998
β1-Adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy?
2000
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
2007 Standout
Myocarditis
2000 Standout
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
2014
Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial
2000
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts
2010
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
The role of cytoskeletal proteins in cardiomyopathies
1998
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human
2007
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
2007
Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy
2000
Risk of Mortality and Heart Failure Exacerbations Associated With Inhaled β-Adrenoceptor Agonists Among Patients With Known Left Ventricular Systolic Dysfunctiona
2003
Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease
1999
A Putative Src Homology 3 Domain Binding Motif but Not the C-terminal Dystrophin WW Domain Binding Motif Is Required for Dystroglycan Function in Cellular Polarity in Drosophila
2007 StandoutNobel
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
1994
Idiopathic Dilated Cardiomyopathy
1994
Safety and efficacy of carvedilol in severe heart failure
1997
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Implantable Cardioverter-Defibrillators in patients with arrhythmogenic right ventricular Dysplasia/Cardiomyopathy
2004
Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres
2007
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families
2008
Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre
2005
Calcium Channel Blockers in Heart Failure
1998
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Comparison of the Effects of AV Nodal Ablation Versus AV Nodal Modification in Patients with Congestive Heart Failure and Uncontrolled Atrial Fibrillation
1998
Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy
2015
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases
2014
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart Failure
1996
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
1995
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure
1985
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2006
Chronic Heart Failure in the United States
1998
Myocarditis
2006 Standout
Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Disease Severity
2004
β-Blockers in Chronic Heart Failure
2003
Early and Delayed Consequences of β 2 -Adrenergic Receptor Overexpression in Mouse Hearts
2000
Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression.
1997
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Improving Survival Rates of Patients With Idiopathic Dilated Cardiomyopathy in Tuscany Over 3 Decades
2013
The Dystrophin Glycoprotein Complex
2004
Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
2009
Guidelines for the study of familial dilated cardiomyopathies
1999
β-Adrenergic Receptor Blockade in Chronic Heart Failure
2000
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
2004
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
β-Adrenergic Receptor Signaling: An Acute Compensatory Adjustment—Inappropriate for the Chronic Stress of Heart Failure?
2000
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)
2000 Standout
Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia
2010
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
1996
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Implantable Cardioverter Defibrillators in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
2013
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Intracoronary Adenovirus-Mediated Delivery and Overexpression of the β 2 -Adrenergic Receptor in the Heart
2000 StandoutNobel
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
2001 StandoutNobel
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
1996 Standout
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
1996
Predicting Sudden Death in the Population
1999
Augmentation of Cardiac Contractility Mediated by the Human β 3 -Adrenergic Receptor Overexpressed in the Hearts of Transgenic Mice
2001 StandoutNobel
Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2
2006
Beneficial Effects of Intravenous and Oral Carvedilol Treatment in Acute Myocardial Infarction
1997
Recommendations for Preparticipation Screening and the Assessment of Cardiovascular Disease in Masters Athletes
2001
Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation
1997
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
1999
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability
2007 StandoutNobel
Beta-Adrenergic Blockade in Chronic Heart Failure
1998
Prognostic Value of Bisoprolol-Induced Hemodynamic Effects in Heart Failure During the Cardiac Insufficiency BIsoprolol Study (CIBIS)
1997
Clinical Effects of β-Adrenergic Blockade in Chronic Heart Failure
1998
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
2000 StandoutNobel
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart
1996
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
1999
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
2001 StandoutScienceNobel
Influence of β -Blockers on Mortality in Chronic Heart Failure
2000
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Gene for Arrhythmogenic Right Ventricular Cardiomyopathy With Diffuse Nonepidermolytic Palmoplantar Keratoderma and Woolly Hair (Naxos Disease) Maps to 17q21
1998
Circumstances of Death and Gross and Microscopic Observations in a Series of 200 Cases of Sudden Death Associated With Arrhythmogenic Right Ventricular Cardiomyopathy and/or Dysplasia
2003
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article*1A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to update the 1997 guidelines for the clinical application of echocardiography)
2003
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Localization of a Gene Responsible for Arrhythmogenic Right Ventricular Dysplasia to Chromosome 3p23
1998
Works of F Camerini being referenced
Familial dilated cardiomyopathy with subclinical skeletal muscle involvement
1996
Changing mortality in dilated cardiomyopathy
1994
Epidemiology of dilated cardiomyopathy: A prospective post-mortem study of 5252 necropsies
1997
A Point Mutation in the 5' Splice Site of the Dystrophin Gene First Intron Responsible for X-Linked Dilated Cardiomyopathy
1996
Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.
1994
Immunosuppressive treatment in myocarditis
1989
Familial dilated cardiomyopathy
1994
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
1993
Left ventricular involvement in right ventricular cardiomyopathy
1989
Evidence from family studies for autoimmunity in dilated cardiomyopathy
1994
Arrhythmias in dilated cardiomyopathy
1986
Right ventricular dysplasia/cardiomyopathy: what is the evolution of the disease?
1994
Afterload reducing agents in congestive cardiomyopathy; a study with a calcium antagonist drug: nifedipine
1980
Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study
1985
Left ventricular involvement in right ventricular cardiomyopathy.
1992
Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy
1997
Nested polymerase chain reaction for high-sensitivity detection of enteroviral RNA in biological samples
1993
Haemodynamic effects of nifedipine in heart failure.
1980
Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group.
1995
Effects of carvedilol on LV function and remodeling in patients with dilated cardiomyopathy with persistent LV dysfunction despite optimal conventional therapy
1998
Right ventricular dysplasia: a clinical and pathological study of two families with left ventricular involvement.
1993